NCT04780217 2024-03-04
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
Clinical Trials
38 trialsNCT05522738 2024-01-08
Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT05432934 2023-12-07
TAP-DEX
University of Saskatchewan
Phase 1/2 Unknown
NCT04753203 2023-10-31
ALCAP
Korean Cancer Study Group
Phase 1/2 Unknown
NCT04348643 2023-04-18
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1/2 Unknown
NCT01898104 2023-03-24
V-shoRT-R3
National Cancer Institute, Naples
Phase 1/2 Unknown
NCT05721872 2023-02-10
Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer
Nazarbayev University
Phase 1/2 Unknown
NCT05587088 2022-10-19
PA001
Hospital Universitario San Ignacio
Phase 1/2 Unknown
NCT03868228 2022-09-28
PIPAC for the Treatment of Colorectal Peritoneal Metastases
Imperial College London
Phase 1/2 Unknown
NCT05016869 2022-08-18
Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT05426811 2022-06-29
Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients
China Medical University, China
Phase 1/2 Unknown
NCT02562963 2022-05-02
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Tsinghua University
Phase 1/2 Unknown
NCT04816045 2021-03-25
Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial
Zealand University Hospital
Phase 1/2 Unknown
NCT04446091 2020-06-24
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)
Zhejiang Cancer Hospital
Phase 1/2 Unknown
NCT03946917 2020-05-12
JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer
Sun Yat-sen University
Phase 1/2 Unknown
NCT04380103 2020-05-08
A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer
ChineseAMS
Phase 1/2 Unknown
NCT04298320 2020-03-16
A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457）
Harbin Medical University
Phase 1/2 Unknown
NCT03638206 2019-12-11
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Phase 1/2 Unknown
NCT03699332 2019-09-13
MMIPC
Radboud University Medical Center
Phase 1/2 Unknown
NCT04008511 2019-07-05
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
China Medical University, China
Phase 1/2 Unknown
NCT03904537 2019-04-05
A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer
Sun Yat-sen University
Phase 1/2 Unknown
NCT00159484 2017-06-27
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 1/2 Unknown
NCT03047525 2017-02-09
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
Harbin Medical University
Phase 1/2 Unknown
NCT02617134 2016-12-06
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1/2 Unknown
NCT02839954 2016-12-06
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1/2 Unknown
NCT02886897 2016-09-01
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors
Sun Yat-sen University
Phase 1/2 Unknown
NCT02781155 2016-05-24
Limiting Chemotherapy Side Effects by Using Moxa
East and North Hertfordshire NHS Trust
Phase 1/2 Unknown
NCT01626963 2016-03-24
Single-port Versus Conventional Laparoscopic Colorectal Surgery
North Tees and Hartlepool NHS Foundation Trust
Phase 1/2 Unknown
NCT01882946 2015-10-07
Safety and Efficacy Study of DCVax-Direct in Solid Tumors
Northwest Biotherapeutics
Phase 1/2 Unknown
NCT00553683 2014-01-14
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Phase 1/2 Unknown
NCT00031616 2013-12-18
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00007826 2013-09-20
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01166035 2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2 Unknown
NCT00478946 2009-01-21
A Study of Picoplatin in Colorectal Cancer
Poniard Pharmaceuticals
Phase 1/2 Unknown
NCT00524706 2008-11-13
Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
Shizuoka Cancer Center
Phase 1/2 Unknown
NCT00154713 2005-09-12
Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
National Taiwan University Hospital
Phase 1/2 Unknown
NCT00057395 2005-06-24
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
Aronex Pharmaceuticals
Phase 1/2 Unknown
NCT00081536 2005-06-24
Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies
Aronex Pharmaceuticals
Phase 1/2 Unknown